sch 34343 has been researched along with Escherichia coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arland, LA; Rotstein, OD; Simmons, RL; Wells, CL | 1 |
| Hare, RS; Lin, CC; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Oden, EM; Rudeen, J | 1 |
2 other study(ies) available for sch 34343 and Escherichia coli Infections
| Article | Year |
|---|---|
In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Drug Administration Schedule; Escherichia coli; Escherichia coli Infections; Female; Lactams; Male; Mice; Peritoneal Diseases; Rats; Rats, Inbred Strains; Skin Diseases, Infectious | 1985 |
Evaluation of the in-vivo efficacy of Sch 34343.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Administration Schedule; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Lactams; Male; Meningitis; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Rabbits | 1985 |